These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 32339298)

  • 1. Strategic issues currently facing the US blood system.
    Fredrick J; Berger JJ; Menitove JE
    Transfusion; 2020 May; 60(5):1093-1096. PubMed ID: 32339298
    [No Abstract]   [Full Text] [Related]  

  • 2. Rolling with the changes.
    Kaufman RM
    Transfusion; 2020 May; 60(5):885. PubMed ID: 32323325
    [No Abstract]   [Full Text] [Related]  

  • 3. The convalescent sera option for containing COVID-19.
    Casadevall A; Pirofski LA
    J Clin Invest; 2020 Apr; 130(4):1545-1548. PubMed ID: 32167489
    [No Abstract]   [Full Text] [Related]  

  • 4. "Because Every Drop Counts": Blood donation during the COVID-19 Pandemic.
    Sahu KK; Raturi M; Siddiqui AD; Cerny J
    Transfus Clin Biol; 2020 Aug; 27(3):105-108. PubMed ID: 32782213
    [No Abstract]   [Full Text] [Related]  

  • 5. Transfusion services operations during the COVID-19 pandemic: Results from AABB survey.
    Pagano MB; Rajbhandary S; Nunes E; Cohn CS
    Transfusion; 2020 Nov; 60(11):2760-2762. PubMed ID: 33217023
    [No Abstract]   [Full Text] [Related]  

  • 6. Supply and demand for plasma-derived medicinal products - A critical reassessment amid the COVID-19 pandemic.
    Hartmann J; Klein HG
    Transfusion; 2020 Nov; 60(11):2748-2752. PubMed ID: 32856742
    [No Abstract]   [Full Text] [Related]  

  • 7. Position paper on the preparation of immune plasma to be used in the treatment of patients with COVID-19.
    Accorsi P; Berti P; de Angelis V; De Silvestro G; Mascaretti L; Ostuni A;
    Blood Transfus; 2020 May; 18(3):163-166. PubMed ID: 32453687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how?
    Tiberghien P; de Lamballerie X; Morel P; Gallian P; Lacombe K; Yazdanpanah Y
    Vox Sang; 2020 Aug; 115(6):488-494. PubMed ID: 32240545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of convalescent plasma in COVID-19 patients in China.
    Zhu M; Hu K; Zhu Z
    Transfus Clin Biol; 2020 Aug; 27(3):168-169. PubMed ID: 32425645
    [No Abstract]   [Full Text] [Related]  

  • 10. How blood from coronavirus survivors might save lives.
    Maxmen A
    Nature; 2020 Apr; 580(7801):16-17. PubMed ID: 32214238
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma from donors convalescent from SARS-CoV-2 infection-A matter of priorities.
    Farrugia A
    Transfus Clin Biol; 2020 Aug; 27(3):167-168. PubMed ID: 32563550
    [No Abstract]   [Full Text] [Related]  

  • 12. Toward universal pathogen reduction of the blood supply (Conference Report, p. 3002).
    Marks P; Verdun N
    Transfusion; 2019 Sep; 59(9):3026-3028. PubMed ID: 31218709
    [No Abstract]   [Full Text] [Related]  

  • 13. Balancing Supply and Demand for Blood during the COVID-19 Pandemic.
    Gehrie EA; Frank SM; Goobie SM
    Anesthesiology; 2020 Jul; 133(1):16-18. PubMed ID: 32550680
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of the COVID-19 pandemic on supply and use of blood for transfusion.
    Stanworth SJ; New HV; Apelseth TO; Brunskill S; Cardigan R; Doree C; Germain M; Goldman M; Massey E; Prati D; Shehata N; So-Osman C; Thachil J
    Lancet Haematol; 2020 Oct; 7(10):e756-e764. PubMed ID: 32628911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 convalescent plasma donor recruitment: beware the Faustian bargains.
    Gniadek TJ; Donnersberger D
    Transfusion; 2020 Jul; 60(7):1643-1644. PubMed ID: 32428966
    [No Abstract]   [Full Text] [Related]  

  • 16. Vox Sanguinis International Forum on transfusion services' response to COVID-19: Summary.
    Yazer MH; Jackson B; Pagano M; Rahimi-Levene N; Peer V; Bueno JL; Jackson RP; Shan H; Amorim-Filho L; Lopes ME; Boquimpani C; Sprogøe U; Topholm Bruun M; Titlestad K; Rushford K; Wood EM; McQuilten ZK; de Angelis V; Delle Donne M; Murphy M; Staves J; Cho D; Nakamura F; Hangaishi A; Callum J; Lin Y; Mogaddam M; Gharehbaghian A; Lozano M
    Vox Sang; 2020 Aug; 115(6):536-542. PubMed ID: 32384164
    [No Abstract]   [Full Text] [Related]  

  • 17. Not throwing away our shot.
    Thorp HH
    Science; 2020 Oct; 370(6514):266. PubMed ID: 33060334
    [No Abstract]   [Full Text] [Related]  

  • 18. Plasma-derived therapy: can the survivors of COVID-19 help the defenseless?
    Majbour N; El-Agnaf O
    Diagnosis (Berl); 2020 Nov; 7(4):373-376. PubMed ID: 32692700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings of the Food and Drug Administration public workshop on pathogen reduction technologies for blood safety 2018 (Commentary, p. 3026).
    Atreya C; Glynn S; Busch M; Kleinman S; Snyder E; Rutter S; AuBuchon J; Flegel W; Reeve D; Devine D; Cohn C; Custer B; Goodrich R; Benjamin RJ; Razatos A; Cancelas J; Wagner S; Maclean M; Gelderman M; Cap A; Ness P
    Transfusion; 2019 Sep; 59(9):3002-3025. PubMed ID: 31144334
    [No Abstract]   [Full Text] [Related]  

  • 20. COVID-19: Convalescent plasma as a potential therapy.
    Van den Berg K; Vermeulen M; Glatt TN; Wasserman S; Barrett CL; Peter J; Brittain D; Louw VJ
    S Afr Med J; 2020 Jun; 110(7):562-563. PubMed ID: 32880317
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.